Bell, Erica http://orcid.org/0000-0002-8483-8497
Boyce, Phil http://orcid.org/0000-0002-9816-7356
Porter, Richard J. http://orcid.org/0000-0002-9607-819X
Bryant, Richard A. http://orcid.org/0000-0002-8695-3966
Malhi, Gin S. http://orcid.org/0000-0002-4524-9091
Article History
Accepted: 28 April 2021
First Online: 21 May 2021
Declarations
:
: This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.
: E. Bell has nothing to disclose. R.A. Bryant has nothing to disclose. P. Boyce has received research support from the National Health and Medical Research Council, speaker fees from Servier and the Australian Medical Forum, educational support from Servier and Lundbeck, has been a consultant for Servier, served on an advisory board for Lundbeck and has served as DSMC Chair for Douglas Pharmaceuticals. R.J. Porter reports non-financial support from CBT-pro, personal fees from Lundbeck, and from Servier, outside the submitted work. G.S. Malhi reports grants from NHMRC, grants from NSW Agency for Clinical Innovation and NSW Ministry of Health, grants from Australian Rotary Health, grants from Ramsay Research and Teaching Fund, grants from American Foundation for Suicide Prevention, personal fees from Elsevier, personal fees from Lundbeck, personal fees from Otsuka, personal fees from Astrazeneca, personal fees from Janssen-Cilag, and personal fees from Servier, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualisation and original draft by EB. Conceptualisation and reviewing by GM, RAB, PB, and RJP. All authors conducted critical revision for important intellectual content and approved the final manuscript.